PUMA Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PUMA Antibodies for advanced research in apoptosis and cell survival mechanisms. PUMA Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PUMA (p53 upregulated modulator of apoptosis) plays a critical role in the apoptotic pathway, acting as a pro-apoptotic member of the Bcl-2 family. PUMA is essential for mediating cell death in response to stress signals and is implicated in various diseases, including cancer. Understanding PUMA function is crucial for developing therapeutic strategies aimed at modulating apoptosis in diseased cells. Researchers can explore PUMA's role in various cellular processes through detailed molecular analysis. Current studies focus on how PUMA influences cell death pathways in different tissue types and disease states. Investigating PUMA's interactions with other proteins provides valuable information about cellular survival mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of apoptotic pathways and their impact on human health.